Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Introduction: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease with high symptom burden, of unknown etiology, with no established treatment. We observed patients with long-standing ME/CFS who got cancer, and who reported improvement of ME/CFS symptoms after chemotherapy inclu...

Full description

Bibliographic Details
Main Authors: Ingrid G. Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J. Tronstad, Kristin Risa, Kine Alme, Marte K. Viken, Benedicte A. Lie, Olav Dahl, Olav Mella, Øystein Fluge
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Medicine
Subjects:
myalgic encephalomyelitis
chronic fatigue syndrome
ME
CFS
cyclophosphamide
clinical trial
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00162/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2020.00162/full

Similar Items